The ultrastructural morphology of the apical conjunctival epithelium is altered in patients with SS. The findings suggest that an intact OSG may play a key role in the maintenance of a healthy ocular surface, possibly by preventing abrasive influences on the apical epithelial cells.
The most frequent complications of uveitis are cataract, glaucoma and uveitic macular edema. The successful management of cataract requires uveitis remission for at least 3 months before surgery and perioperative intensification of anti‐inflammatory medication in order to prevent uveitis recurrences. Intraocular strategy is also important for the final.
outcome. Uveitic glaucoma management comprises medical and surgical treatment, considering that about 30% of cases.
will need invasive methods. Uveitic macular edema is commonly seen in intermediate, posterior or panuveitis. The base of treatment are corticosteroids and also dealing with the underlying cause of edema. The role of immunosuppressives and biological agents is very important too.
Loss of vision due to eye metastasis is generally uncommon, representing an ophthalmological diagnostic and therapeutic challenge. We here report a case of a smoker patient finally diagnosed with lung cancer, whose initial symptom was visual loss due to choroidal metastasis. Given that the majority of subjects presenting with uveal metastasis have already developed other distant metastases as well, a complete diagnostic work-up of these patients is always required. Despite being rare, eye metastasis from a lung malignancy should always be suspected in smokers presenting with progressive vision deterioration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.